LEO LUZNIK to Combined Modality Therapy
This is a "connection" page, showing publications LEO LUZNIK has written about Combined Modality Therapy.
Connection Strength
0.235
-
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide. Blood. 2019 11 21; 134(21):1802-1810.
Score: 0.122
-
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy. Haematologica. 2025 Nov 01; 110(11):2635-2646.
Score: 0.044
-
Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study. Lancet HIV. 2020 09; 7(9):e602-e610.
Score: 0.032
-
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 2015 May 07; 125(19):3024-31.
Score: 0.022
-
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol. 2010 Jun; 21(6):1203-1210.
Score: 0.015